✦ LIBER ✦

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

✍ Scribed by Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bruna; Schipani, Stefano; Cozzarini, Cesare; Bordonaro, Roberto; Villa, Eugenio

Book ID: 119318842
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 117 KB
Volume: 44
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2003.11.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line chemotherapy with weekly pac

Second-line chemotherapy with weekly paclitaxel in patients with advanced non-small-cell lung cancer

✍ Luis Ángel León Mateos; Juan Fernando Cueva Bañuelos; María Teresa Curiel García 📂 Article 📅 2002 🏛 Springer Milan 🌐 Spanish ⚖ 49 KB

Phase II study of low-dose weekly paclit

Phase II study of low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer

✍ O. Juan; V. Alberola; A. Rocher; R. Casany; V. Carañana; J.M. Campos; A. Albert; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 347 KB

794 Weekly paclitaxel (W-PAC) as second-

794 Weekly paclitaxel (W-PAC) as second-line therapy in cisplatin pretreated patients with advanced non-small cell lung cancer (NSCLC)

✍ G.L. Ceresoli; V. Gregorc; S. Cordio; K. Bencardino; A. Spreafico; C. Cozzarini; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II study of weekly plitidepsin as

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

✍ Eisen, Tim; Thatcher, Nick; Leyvraz, Serge; Miller, Wilson H.; Couture, Felix; L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase I/II study of cisplatin combined w

Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer

✍ Yoshimura, N; Kudoh, S; Mukohara, T; Yamauchi, S; Yamada, M; Kawaguchi, T; Nakao 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Second line treatment of antiangiogenic

Second line treatment of antiangiogenic therapy with celecoxib and weekly paclitaxel for advanced non-small cell lung cancer (NSCLC)

✍ Stani, Simonetta Chiara; Sarmiento, Roberta; Mansueto, Giovanni; Bonginelli, Pao 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB